Congleton Jon
SEC insider (Form 3/4/5 filer). CIK 0001644975. Chief Executive Officer at Mineralys Therapeutics, Inc. (MLYS) and 2 other issuers. 28 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in RADNOR, PA.
Companies Congleton Jon has filed insider reports for
- Mineralys Therapeutics, Inc. (MLYS): Director, Officer, Chief Executive Officer
- IMMUNIC, INC. (IMUX): Director
- Avalyn Pharma Inc. (AVLN): Director
Congleton Jon
CIK: 0001644975
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Sep 30, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect75K shares at avg. $25.46$1.9M - Jul 13, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect10.7K shares at avg. $27.24$291K - Jul 5, 2026IMUX
IMMUNIC, INC.
AwardDirectStock Option
25.4K shares- - Jun 30, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect58K shares at avg. $25.94$1.5M - Jun 30, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect17K shares at avg. $26.82$456K - Jun 29, 2026IMUX
IMMUNIC, INC.
AwardDirectStock Option
50.7K shares- - Apr 29, 2026AVLN
Avalyn Pharma Inc.
AwardDirectStock Option (Right to Buy)
27K shares- - Apr 13, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect15.7K shares at avg. $26.83$422K - Mar 31, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect55.2K shares at avg. $26.54$1.5M - Mar 31, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect453 shares at avg. $27.05$12K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 |  MLYS Mineralys Therapeutics, Inc. | Sale | 75,000 | $25.46 | $1,909,665 | Direct |
| Jul 13, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 10,700 | $27.24 | $291,441 | Direct |
| Jul 5, 2026 |  IMUX IMMUNIC, INC. | Award Stock Option | 25,370 | - | - | Direct |
| Jun 30, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 58,000 | $25.94 | $1,504,706 | Direct |
| Jun 30, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 17,000 | $26.82 | $455,896 | Direct |
| Jun 29, 2026 | IMUX IMMUNIC, INC. | Award Stock Option | 50,740 | - | - | Direct |
| Apr 29, 2026 |  AVLN Avalyn Pharma Inc. | Award Stock Option (Right to Buy) | 26,978 | - | - | Direct |
| Apr 13, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 15,730 | $26.83 | $421,979 | Direct |
| Mar 31, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 55,183 | $26.54 | $1,464,474 | Direct |
| Mar 31, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 453 | $27.05 | $12,254 | Direct |
1-10 of 28 transactions